Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10


High levels of serum β2-microglobulin predict severity of coronary artery disease.

You L, Xie R, Hu H, Gu G, Zheng H, Zhang J, Yang X, He X, Cui W.

BMC Cardiovasc Disord. 2017 Mar 1;17(1):71. doi: 10.1186/s12872-017-0502-9.


Prognostic Significance of Initial Serum Albumin and 24 Hour Daily Protein Excretion before Treatment in Multiple Myeloma.

Chen JH, Hsu SN, Huang TC, Wu YY, Lin C, Chang PY, Chen YC, Ho CL.

PLoS One. 2015 Jun 8;10(6):e0128905. doi: 10.1371/journal.pone.0128905. eCollection 2015.


β2-microglobulin, cystatin C, and creatinine and risk of symptomatic peripheral artery disease.

Joosten MM, Pai JK, Bertoia ML, Gansevoort RT, Bakker SJ, Cooke JP, Rimm EB, Mukamal KJ.

J Am Heart Assoc. 2014 Jun 30;3(4). pii: e000803. doi: 10.1161/JAHA.114.000803.


Standard and novel imaging methods for multiple myeloma: correlates with prognostic laboratory variables including gene expression profiling data.

Waheed S, Mitchell A, Usmani S, Epstein J, Yaccoby S, Nair B, van Hemert R, Angtuaco E, Brown T, Bartel T, McDonald J, Anaissie E, van Rhee F, Crowley J, Barlogie B.

Haematologica. 2013 Jan;98(1):71-8. doi: 10.3324/haematol.2012.066555. Epub 2012 Jun 24.


Novel immunotherapies.

Yi Q.

Cancer J. 2009 Nov-Dec;15(6):502-10. doi: 10.1097/PPO.0b013e3181c51f0d. Review.


Comparison of serum beta 2-microglobulin and 24 hour urinary creatinine clearance as a prognostic factor in multiple myeloma.

Yun JP, Suh C, Lee E, Chang JW, Yang WS, Park JS, Park SK.

J Korean Med Sci. 2006 Aug;21(4):639-44.


The primary mediastinal clear cell lymphoma of B-cell type has variable defects in MHC antigen expression.

Möller P, Lämmler B, Herrmann B, Otto HF, Moldenhauer G, Momburg F.

Immunology. 1986 Nov;59(3):411-7.


Prognostic factors and classification in multiple myeloma.

San Miguel JF, Sànchez J, Gonzalez M.

Br J Cancer. 1989 Jan;59(1):113-8.


Expression of beta-2-microglobulin by nasopharyngeal carcinoma.

Shiu W, Leung SF, Leung WT, Ho S, Tao M.

Br J Cancer. 1992 Sep;66(3):555-7.

Supplemental Content

Support Center